David Chi, MD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, David Chi, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
David Chi, MD: 4 sponsored US clinical trials, none currently recruiting.
David Chi, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Recurrent Acute Otitis Media, with 1 trials.
Upper-quartile sponsor footprint
David Chi, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Posterior vs. Anterior Tympanostomy Tube Placement
NCT06191562
Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity
NCT04879823
Non-Opioid Pain Medications After Intracapsular Adenotonsillectomy
NCT04791761
Non-opioids for Analgesia After Adenotonsillectomy in Children
NCT03618823
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
How the David Chi, MD early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Recurrent Acute Otitis Media (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
David Chi, MD: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
David Chi, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this David Chi, MD page
4 registered trials is a research-attention snapshot, not an endorsement of David Chi, MD or any single study.
- None of David Chi, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Recurrent Acute Otitis Media is the condition David Chi, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Recurrent Acute Otitis Media trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. David Chi, MD pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.